NCT06926452

Brief Summary

In clinical practice most patients' first concern is esthetics, soft tissue grafting is becoming routine in clinical practice to make up for the deficiency in supra-crestal tissue dimension that typically follows tooth loss. The edentulous site experiences major qualitative and quantitative changes because of a number of sequential events that occur after tooth extraction. Ridge dimensional alterations of the underlying bone and the soft tissue architecture overlaying it are the consequence of the socket healing process. To maintain the remaining teeth, aesthetic jaw support and optimal food chewing, lost teeth must be replaced. The teeth adjacent to and opposing a missing tooth will eventually tip, shift, and migrate, disrupting normal function. One integral part of the new strategy for treating periodontal diseases is thought to be surgical periodontal operations. Soft tissue grafting has become more frequently utilized to improve the aesthetics of teeth and dental implant sites by treating mucogingival abnormalities, restoring an appropriate width of keratinized tissue, and enhancing tissue thickness. SCTG has its own limitations, such as lack of graft availability, need for a second surgical site, proximity to palatine neurovascular complex and unaesthetic tissue contour at the recipient site. Due to these limitations, investigations on more regenerative nature techniques have been explored such as PRF, Using PRF instead of SCTG has the added value of decreasing discomfort and postoperative pain after the surgical procedure due to having additional donor site, To the best of our knowledge testing multi-layer PRF against SCTG in pontic site augmentation was never done before.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started May 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
May 2025Sep 2026

First Submitted

Initial submission to the registry

April 7, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 13, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

April 13, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

April 7, 2025

Last Update Submit

April 7, 2025

Conditions

Keywords

Pontic site augmentation

Outcome Measures

Primary Outcomes (1)

  • Keratinized tissue thickness

    6 months

Study Arms (2)

Control

ACTIVE COMPARATOR
Procedure: Pontic site augmentation with sub-epithelial connective tissue graft.

Test

EXPERIMENTAL
Procedure: Pontic site augmenation using multi-layered platelet rich fibrin

Interventions

Pontic site augmentation with sub-epithelial connective tissue graft.

Control

Pontic site augmenation using multi-layered platelet rich fibrin

Test

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults from the age of 18 - 40 years
  • Patients with missing maxillary teeth/tooth in the area from 2nd premolar to 2nd premolar with ridge defect according to Seibert classification (Class I, II and III).
  • Intact gingival tissue with at least 2mm keratinized tissue.
  • Periodontally healthy patients.
  • Patients accepts to provide informed consent.

You may not qualify if:

  • Smokers.
  • Pregnant females.
  • Handicapped and mentally challenged patients.
  • Systemic disease compromising wound healing.
  • Active soft tissue infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Joseph Osama Kostandy, Bachelor Degree of dentsitry

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post-graduate candidate in Cairo university

Study Record Dates

First Submitted

April 7, 2025

First Posted

April 13, 2025

Study Start

May 1, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 13, 2025

Record last verified: 2025-04